The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer

Purpose: DNA demethylating agents have shown clinical effectiveness in hematological and solid tumors. This trial tested the safety, efficacy, and treatment outcomes of decitabine-based chemotherapy or combined with immunotherapy in recurrent ovarian cancer patients. Patients and methods: Fifty-five...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Zhang, Yan, Mei, Qian, Liu, Yang, Li, Xiang, Brock, Malcolm V., Chen, Meixia, Dong, Liang, Shi, Lu, Wang, Yao, Guo, Mingzhou, Nie, Jing, Han, Weidong
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599090/
https://ncbi.nlm.nih.gov/pubmed/28932630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1323619
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars